PROLUTEX sol inj 25 mg/1.112ml flac 7 pce
7680632250085
CH-63225
G03DA04
07.08.3.
1 / 3
google
Details
- Product number
- 6322501
- CPT
- -
- Packaging group
- 7
- Unit
- Durchstechflasche(n)
- Composition
- progesteronum 25 mg, hydroxypropylbetadexum, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile ad solutionem pro 1.112 ml corresp. natrium 0.05 mg.
Articles (1)
Prolutex 25 mg, soluzione iniettabile
soluzione
7
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.05 MG | Substance | HBESI |
Authorization holder
IBSA Institut Biochimique SA
None Lugano
Authorization information
- Swissmedic authorization number
- 63225
- Drug name
- Prolutex, soluzione iniettabile
- Galenic form
- LSINJ
- ATC Code
- G03DA04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/06/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.08.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PROLUTEX sol inj 25 mg/1.112ml flac 7 pce
- Description (DE)
- PROLUTEX Inj Lös 25 mg/1.112ml Durchstf 7 Stk
- Market launch
- 13/06/2014
- Narcotic (BTM)
- No